Mar 24, 2019
Graham Kelly, CEO, Noxopharm discusses the company's lead clinical asset, Veyonda, a first-in-class chemotherapy and radiation enhancer that has immuno-oncology properties. Veyonda has potential utility across solid tumors and boosts the effect of radiation therapy 2-3x in cancer cells. It has already shown positive...
Mar 19, 2019
Jani Tuomi, Co-Founder, imaware and Kelly O'Neill, author and rheumatoid arthritis warrior talk about how at-home blood testing can empower patients with vital information to inform their discussions with doctors. Both talk about how easy self testing for rheumatoid arthritis is a smart way to follow up on early...
Mar 13, 2019
Frank Ochberg MD is a psychiatrist, pioneer in trauma science, and co-founder of the Trust for Trauma Journalism, an organization with the goal of providing funding to advance exemplary reporting and the care of journalists who are bearing witness to violence, conflict and tragedy. We talk about journalists as first...
Mar 6, 2019
Dr. Dan Alkon, President and Chief Scientific Officer, Neurotrope is an internationally recognized pioneer in research on brain based neural networks, the molecular basis of memory and degenerative brain disorders. Neurotrope has seen very promising results in clinical trials with Bryostatin-1 with patients with...